Table 3.
Tumors’ characteristics
| |
Stomach |
Duodenum |
Jejunum |
Ileum |
Colon |
Appendix |
Rectum |
Pancreas |
Total |
|---|---|---|---|---|---|---|---|---|---|
| n = 16 | n = 9 | n = 1 | n = 4 | n = 8 | n = 8 | n = 99 | n = 23 | N = 168 (%) | |
|
Size |
|
|
|
|
|
|
|
|
|
| <1 cm |
2 |
0 |
0 |
0 |
1 |
0 |
39 |
2 |
44 (26.19) |
| 1-2 cm |
1 |
4 |
0 |
2 |
1 |
3 |
31 |
8 |
50 (29.76) |
| >2 cm |
9 |
5 |
1 |
2 |
5 |
1 |
15 |
13 |
51 (30.36) |
| Unclear |
4 |
0 |
0 |
0 |
1 |
4 |
14 |
0 |
23 (13.69) |
|
Stage |
|
|
|
|
|
|
|
|
|
| T1N0M0 |
4 |
0 |
0 |
0 |
1 |
2 |
43 |
5 |
55 (32.74) |
| T2N0M0 |
1 |
3 |
0 |
0 |
0 |
1 |
17 |
5 |
27 (16.07) |
| T3N0M0 |
2 |
1 |
0 |
1 |
2 |
4 |
2 |
7 |
19 (11.31) |
| T4N0M0 |
1 |
2 |
0 |
0 |
0 |
0 |
0 |
4 |
7 (4.17) |
| TanyN1M0 |
5 |
1 |
1 |
3 |
3 |
0 |
10 |
1 |
24 (14.29) |
| TanyNanyM1 |
2 |
2 |
0 |
0 |
2 |
1 |
6 |
1 |
14 (7.74) |
| Unclear |
1 |
0 |
0 |
0 |
0 |
0 |
21 |
0 |
22 (13.69) |
|
WHO 2010 |
|
|
|
|
|
|
|
|
|
| NET/G1 |
0 |
2 |
0 |
0 |
1 |
0 |
26 |
5 |
34 (20.23) |
| NET/G2 |
0 |
1 |
0 |
0 |
1 |
0 |
3 |
2 |
7 (4.17) |
| NEC/G3 |
1 |
0 |
0 |
0 |
2 |
0 |
4 |
5 |
12 (7.14) |
| Unclear |
15 |
6 |
1 |
4 |
4 |
8 |
66 |
11 |
115 (68.45) |
|
WHO 2000 |
|
|
|
|
|
|
|
|
|
| WDET |
0 |
2 |
1 |
0 |
0 |
0 |
5 |
4 |
12 (7.14) |
| WDEC |
0 |
2 |
0 |
0 |
0 |
0 |
5 |
0 |
7 (4.17) |
| PDEC |
1 |
2 |
0 |
0 |
0 |
0 |
4 |
6 |
13 (7.74) |
| Unclear | 15 | 3 | 0 | 4 | 8 | 8 | 85 | 13 | 136 (80.95) |
TNM: tumor-node-metastasis approach [11]; NET, neuroendocrine tumor; NEC, neuroendocrine carcinoma; G1, grade 1; G2, grade 2; G3, grade 3; WDET, well differentiated endocrine tumour; WDEC, well differentiated endocrine carcinoma; PDEC, poorly differentiated endocrine carcinoma.